The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort
- 10 May 2005
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 21 (6) , 515-524
- https://doi.org/10.1002/dmrr.561
Abstract
Background To evaluate the prevalence of the metabolic syndrome (MS) and its components in a population-based cohort, and to analyse the association between gender, environmental conditions, C-reactive protein (CRP), and the syndrome. Methods Out of 1877 subjects aged 45–64, who represented all the patients of six family physicians, representative of the sanitary districts of Asti (north-western Italy), 88% accepted to participate in an interview on personal habits, and several clinical and laboratory measurements. Results The MS (National Cholesterol Education Program criteria) was present in 24% of males and 22% of females. Males had a significantly higher percentage of hyperglycaemia, hypertension, hypertriglyceridemia, whereas females had a higher prevalence of central obesity and low HDL-cholesterol. In a multiple logistic regression model, the MS was significantly associated with increasing age, BMI, and >30 g/day alcohol intake (OR = 1.42; 95% CI 1.27–1.58), and negatively to higher education level (OR = 0.52; 95% CI 0.28–0.99) and moderate exercise (OR = 0.65; 95% CI 0.57–0.76). CRP levels are highly correlated to BMI and the components of the syndrome. The association between CRP and the MS remains significant in women only, in a multivariate analysis, after multiple adjustments (OR = 1.73; 95% CI 1.42–2.11). Higher CRP levels, correlated to smoking and, inversely, to alcohol intake, identify a further 12% of the cohort at higher cardiovascular risk. Conclusions The MS affects more than 20% of this middle-aged cohort, but more than 30%, with higher CRP levels are at high cardiovascular risk. Healthier lifestyle habits are inversely associated with the MS and CRP levels, suggesting the need for strategies and their implementation in the general population. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 59 references indexed in Scilit:
- The Metabolic Syndrome as Predictor of Type 2 DiabetesDiabetes Care, 2003
- NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and OlderDiabetes, 2003
- Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic SyndromeDiabetes Care, 2003
- The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged MenJAMA, 2002
- Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort StudyAmerican Journal of Epidemiology, 2002
- Global and societal implications of the diabetes epidemicNature, 2001
- The Continuing Epidemics of Obesity and Diabetes in the United StatesJAMA, 2001
- Cardiovascular Morbidity and Mortality Associated With the Metabolic SyndromeDiabetes Care, 2001
- Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.Diabetes, 1998
- Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular DiseaseDiabetes Care, 1991